Clifton Mining Company (OTCBB: CFTN) (the "Company") - "Annual Meeting Voting Results"
MWN-AI** Summary
Clifton Mining Company (OTCBB: CFTN) held its annual meeting on October 17, 2025, at the Alpine Art Center in Alpine, Utah, where shareholders voted on key corporate actions. The meeting saw a quorum of approximately 64% of shares voted, with all six director nominees approved. Jessica Marr, Michael Marr, and Erica Marr received around 78% of votes, while K. Bruce Jones received a robust 89%. Conversely, Kenneth S. Friedman and Scott S. Moeller garnered lower support, attaining 66% and 65%, respectively. Notably, the shareholders ratified Sadler, Gibb & Associates, LLC's appointment as independent auditors with about 90% approval, aligning with the Board of Directors' recommendation.
During the meeting, Michael Marr shared insights from his investments in residential and commercial real estate and highlighted the productive status of Desert Hawk Gold Corp., which is reportedly yielding around 6 ounces of gold per day. Ken Friedman addressed the changing landscape of precious metals pricing, indicating a strategic pivot for Clifton from survival mode to actively seeking partnerships to explore valuable mineral targets within its properties.
Additionally, Paul Schwitzer from American Biotech Labs reported strong sales growth for 2025, surpassing previous years, particularly through Amazon, where re-order rates from first-time users remain substantial at 70%. The meeting concluded around 2:30 pm, reinforcing Clifton Mining Company's commitment to strategic growth and operational efficiency. Investors should be aware of potential risks associated with forward-looking statements as per the Private Securities Litigation Reform Act of 1995. As a publicly traded company, Clifton Mining maintains its trading status on the OTC Markets under the symbol "CFTN."
MWN-AI** Analysis
Clifton Mining Company (OTCBB: CFTN) recently held its annual meeting, delivering positive signals to shareholders through the unanimous election of its six director nominees and the ratification of its independent auditors. Notably, the support for the nominated directors ranged impressively from 65% to 89%, indicating a substantial backing from the shareholders and a potential alignment with the strategic vision of management.
The meeting highlighted a significant pivot in the company’s approach to precious metals, influenced by the changing pricing landscape. Ken Friedman discussed the strategic shift from mere survival to seeking partnerships for developing high-value mineral targets in the Clifton Shear Zones. This proactive strategy may yield attractive opportunities, particularly considering the current bull market for precious metals, which is characterized by heightened investor interest and potential price increases.
Moreover, the report from American Biotech Labs underscores a robust sales performance trajectory, significantly bolstered by continued growth in Amazon sales. This trend indicates a strong consumer base, with around 70% of first-time users reordering products, providing a resilient revenue stream that could enhance cash flow stability.
For potential investors, Clifton Mining appears well-positioned to leverage the current precious metals market while also benefiting from its involvement in growing biotech initiatives. While the shift towards developing its mining assets is promising, investors should remain cognizant of the inherent risks in exploration and operational execution.
Given these insights, maintaining a watchful eye on Clifton’s strategic developments and market conditions would be prudent, as increased collaboration and operational advancements may yield growth opportunities. For investors considering exposure to this sector, Clifton Mining may offer a compelling investment proposition within a broader portfolio of precious metals and associated industries.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
AMERICAN FORK, Utah, Oct. 28, 2025 /CNW/ - Clifton Mining Company held its annual meeting at 12:30 pm on October 17, 2025 at the Alpine Art Center in Alpine, Utah. The Company reports that shareholders approved the election of each of the six (6) director nominees. Each director nominee received affirmative votes calculated from a quorum of approximately 64% of the shares voted, excluding abstentions and broker non-votes, as follows (all percentages are rounded):
Director Nominee (Term) | For |
Jessica Marr (Term expiring 2026) | 78 % |
Michael Marr (Term expiring 2027) | 79 % |
Erica Marr (Term expiring 2027) | 78 % |
K. Bruce Jones (Term expiring 2028) | 89 % |
Kenneth S. Friedman (Term expiring 2028) | 66 % |
Scott S. Moeller (Term expiring 2028) | 65 % |
Shareholders also ratified the appointment of Sadler, Gibb & Associates, LLC as the Company's independent auditors, with affirmative votes from approximately 90% of the shares voted. The Board of Directors had recommended a vote for this proposal.
Three reports were given at the meeting, one from Michael Marr, who provided some background as an investor in residential and commercial real estate and how he came to be interested as an investor in both Desert Hawk Gold Corp. and Clifton Mining Company. He also provided an update that Desert Hawk operations, stating there is still much work to be done, but the operations are producing approximately 6 ounces of gold per day and are cash flow positive. Ken Friedman discussed the sea-change in the pricing of precious metals and how that has led to a major change in Clifton strategy, from seeking to survive (and being one of the few exploration companies to do so) to actively courting a partner to develop the Clifton Shear Zones and other potential high-value mineral targets, of which there are a number on the Clifton Mining properties. A final report was given by Paul Schwitzer, Vice President of Marketing and Sales for American Biotech Labs, LLC a wholly owned American Silver, LLC entity, of which the Company is a Member. Mr. Schwitzer reported that product sales for 2025 are a head of last year and that Amazon sales have also continued to grow significantly over the past three years. He also reported that Amazon is still showing that around 70% of first-time users have re-ordered the products. The company has also continued to focus on increasing sales in the medical supply markets.
The meeting adjourned around 2:30 pm.
Clifton trades on the OTC Markets under the symbol: "CFTN".
Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.
SOURCE Clifton Mining Company
View original content: http://www.newswire.ca/en/releases/archive/October2025/28/c9085.html
FAQ**
What were the main factors contributing to the shareholder support for the election of the director nominees at Clifton Mining Co CFTN's annual meeting, particularly the varying percentages of votes received by each nominee?
How does the significant approval rating (approximately 90%) for Sadler, Gibb & Associates, LLC as independent auditors reflect investor confidence in the financial management of Clifton Mining Co CFTN?
In what ways is Clifton Mining Co CFTN planning to leverage the sea-change in precious metal pricing to enhance its strategy and develop the Clifton Shear Zones?
Considering the positive sales trends reported by American Biotech Labs, how might Clifton Mining Co CFTN utilize this momentum to strengthen its market position in both the mining and medical supply sectors?
**MWN-AI FAQ is based on asking OpenAI questions about Clifton Mining Co (OTC: CFTN).
NASDAQ: CFTN
CFTN Trading
-14.95% G/L:
$0.1701 Last:
1,990 Volume:
$0.18 Open:
